Related Experiment Video
Updated: Mar 26, 2026

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay
Published on: May 5, 2016
Antibiotic-tolerant Staphylococcus aureus Biofilm Persists on Arthroplasty Materials
Kenneth L Urish1, Peter W DeMuth2, Brian W Kwan3
1The Magee Bone & Joint Center, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, 15212, USA. urishk2@upmc.edu.
Background:
The continued presence of biofilm may be one cause of the high risk of failure observed with irrigation and débridement with component retention in acute periprosthetic joint infection (PJI). There is a poor understanding of the role of biofilm antibiotic tolerance in PJI.
Questions/Purposes:
(1) Do increasing doses of cefazolin result in decreased viable biofilm mass on arthroplasty materials? (2) Is cefazolin resistance phenotypic or genotypic? (3) Is biofilm viability a function of biofilm depth after treatment with cefazolin? (4) Is the toxin-antitoxin system, yoeB expression, associated with antibiotic stress?
Methods:
Methicillin-sensitive Staphylococcus aureus biofilm was cultured on total knee arthroplasty (TKA) materials and exposed to increasing doses of cefazolin (control, 0.5, 1.0, 10.0, 100.0 μg/mL). Quantitative confocal microscopy and quantitative culture were used to measure viable biofilm cell density. To determine if cefazolin resistance was phenotypic or genotypic, we measured minimum inhibitory concentration (MIC) after exposure to different cefazolin concentrations; changes in MIC would suggest genotypic features, whereas unchanged MIC would suggest phenotypic behavior. Finally, quantitative reverse transcription-polymerase chain reaction was used to quantify expression of yoeB levels between biofilm and planktonic bacteria after exposure to 1 μg/mL cefazolin for 3 hours.
Results:
Although live biofilm mass was reduced by exposure to cefazolin when compared with biofilm mass in controls (39.2 × 10(3) ± 26.4 × 10(3) pixels), where the level after 0.5 µg/mL exposure also showed reduced mass (20.3 × 10(3) ± 11.9 × 10(3) pixels), no further reduction was seen after higher doses (mass at 1.0 µg/mL: 5.0 × 10(3) pixels ± 1.1 × 10(3) pixels; at 10.0 µg/mL: 6.4 × 10(3) ± 9.6 × 10(3) pixels; at 100.0 µg/mL: 6.4 × 10(3) ± 3.9 × 10(3)). At the highest concentration tested (100 µg/mL), residual viable biofilm was present on all three materials, and there were no differences in percent biofilm survival among cobalt-chromium (18.5% ± 15.1%), polymethylmethacrylate (22.8% ± 20.2%), and polyethylene (14.7% ± 10.4%). We found that tolerance was a phenotypic phenomenon, because increasing cefazolin exposure did not result in changes in MIC as compared with controls (MIC in controls: 0.13 ± 0.02; at 0.5 µg/mL: 0.13 ± 0.001, p = 0.96; at 1.0 µg/m: 0.14 ± 0.04, p = 0.95; at 10.0 µg/m: 0.11 ± 0.016, p = 0.47; at 100.0 µg/m: 0.94 ± 0.047, p = 0.47). Expression of yoeB after 1 µg/mL cefazolin for 3 hours in biofilm cells was greater in biofilm but not in planktonic cells (biofilm: 62.3-fold change, planktonic cells: -78.8-fold change, p < 0.001).
Conclusions:
Antibiotics are inadequate at complete removal of the biofilm from the surface of TKA materials. Results suggest that bacterial persisters are responsible for this phenotypic behavior allowing biofilm high tolerance to antibiotics.
Clinical Relevance:
Antibiotic-tolerant biofilm suggests a mechanism behind the poor results in irrigation and débridement for acute TKA PJI.
Insights
Cefazolin treatment reduced biofilm mass on knee arthroplasty materials, but did not eliminate it. This antibiotic tolerance in biofilm, likely due to bacterial persisters, explains poor outcomes in periprosthetic joint infection treatment.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Microbiology
Background:
- Periprosthetic joint infection (PJI) has high failure rates with irrigation and débridement, potentially due to persistent bacterial biofilm.
- The role of biofilm antibiotic tolerance in PJI outcomes is not well understood.
Purpose of the Study:
- To investigate if increasing cefazolin doses reduce viable biofilm mass on arthroplasty materials.
- To determine if cefazolin resistance in biofilm is phenotypic or genotypic.
- To assess if biofilm viability depends on depth after cefazolin treatment.
- To examine the association between yoeB toxin-antitoxin system expression and antibiotic stress.
Main Methods:
- Methicillin-sensitive Staphylococcus aureus biofilm cultured on total knee arthroplasty (TKA) materials.
- Exposure to increasing cefazolin doses (0.5–100.0 μg/mL).
- Quantitative confocal microscopy, quantitative culture, and minimum inhibitory concentration (MIC) assays.
- Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) for yoeB expression.
Main Results:
- Cefazolin reduced biofilm mass compared to controls, but higher doses showed no additional reduction.
- Residual viable biofilm remained on all tested materials (cobalt-chromium, polymethylmethacrylate, polyethylene) at 100 μg/mL cefazolin.
- Cefazolin tolerance was phenotypic, as MIC did not change with increasing drug exposure.
- yoeB expression significantly increased in biofilm cells but decreased in planktonic cells after cefazolin exposure.
Conclusions:
- Antibiotics are insufficient for complete biofilm eradication from TKA materials.
- Bacterial persisters likely cause phenotypic antibiotic tolerance, contributing to high biofilm tolerance.
- Antibiotic-tolerant biofilm offers a potential explanation for poor outcomes in irrigation and débridement for acute TKA PJI.
Related Concept Videos
Biofilms
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA

